FDA NDC Directory · JSON-LD · Markdown

PYLERA

NDC 61269-381 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameBISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE
Labeler / ManufacturerH2-Pharma, LLC
Marketing categoryNew Drug Application (innovator) · App NDA050786
Dosage form / routeCAPSULE · ORAL
Active ingredientsBISMUTH SUBCITRATE POTASSIUM (140 mg/1)
METRONIDAZOLE (125 mg/1)
TETRACYCLINE HYDROCHLORIDE (125 mg/1)
Marketing started20250818
Package count1

External sources

Source: openFDA. Public-domain (CC0).